SE7906273L - Sett att framstella en gammaglobulinlosning - Google Patents

Sett att framstella en gammaglobulinlosning

Info

Publication number
SE7906273L
SE7906273L SE7906273A SE7906273A SE7906273L SE 7906273 L SE7906273 L SE 7906273L SE 7906273 A SE7906273 A SE 7906273A SE 7906273 A SE7906273 A SE 7906273A SE 7906273 L SE7906273 L SE 7906273L
Authority
SE
Sweden
Prior art keywords
prepare
way
gammaglobulin
solution
gamma globulin
Prior art date
Application number
SE7906273A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
U Ahrens
Original Assignee
Blutspendedienst Dt Rote Kreuz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blutspendedienst Dt Rote Kreuz filed Critical Blutspendedienst Dt Rote Kreuz
Publication of SE7906273L publication Critical patent/SE7906273L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SE7906273A 1978-08-16 1979-07-23 Sett att framstella en gammaglobulinlosning SE7906273L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782835843 DE2835843A1 (de) 1978-08-16 1978-08-16 Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung

Publications (1)

Publication Number Publication Date
SE7906273L true SE7906273L (sv) 1980-02-16

Family

ID=6047152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7906273A SE7906273L (sv) 1978-08-16 1979-07-23 Sett att framstella en gammaglobulinlosning

Country Status (7)

Country Link
US (1) US4312949A (de)
JP (1) JPS5547614A (de)
AT (1) AT368885B (de)
DE (1) DE2835843A1 (de)
FR (1) FR2433342A1 (de)
GB (1) GB2030570B (de)
SE (1) SE7906273L (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
ATE66616T1 (de) * 1982-08-30 1991-09-15 Baxter Int Verfahren zur herstellung von gamma-globulin enthaltenden zusammensetzungen.
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
US5256771A (en) * 1990-04-03 1993-10-26 Miles Inc. Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use

Also Published As

Publication number Publication date
GB2030570A (en) 1980-04-10
US4312949A (en) 1982-01-26
AT368885B (de) 1982-11-25
FR2433342A1 (fr) 1980-03-14
GB2030570B (en) 1982-09-02
JPS5547614A (en) 1980-04-04
ATA505179A (de) 1982-04-15
DE2835843A1 (de) 1980-02-28

Similar Documents

Publication Publication Date Title
SE7906273L (sv) Sett att framstella en gammaglobulinlosning
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
DK153385A (da) Monoklonale antistoffer, hybridoma-cellelinier samt fremgangsmaade til fremstilling af monoklonale antistoffer
DK283881A (da) Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
NO159698C (no) Fremgangsm te til pasteurisering av human-fibrinoge
DE58905514D1 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt.
DE3769066D1 (de) Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
ATE866T1 (de) Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung.
Frieden et al. Changes in serum proteins in amphibian metamorphosis
ATE111519T1 (de) Familie von modifizierten antikörpern mit hoher affinität zur behandlung von krebs.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
JPS56137156A (en) Method of and reagent for measuring -lipo protein
DK579185D0 (da) Pyrrolobenzimidazoler, fremgangsmaade til fremstilling heraf samt laegemidler med indhold heraf
DE3875930D1 (de) Bleichbaeder mit bleichbeschleunigenden substanzen.
DE3062792D1 (en) A process in purification and concentration of the factor viii-complex
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
DK439082A (da) 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf
SE7504196L (sv) Sett att framstella en proteinhaltig produkt.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
ATE3981T1 (de) Verfahren zur gewinnung von alpha-2-sbglykoprotein.
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7906273-3